Child Categories
Food & Drug Law
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
November 20, 2026
Amy L. McGuire, I. Glenn Cohen, Dominic Sisti et al., Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement, 7 JAMA…
-
Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods
November 19, 2026
Cameron Faustman, Daniel Aaron, Nicole Negowetti & Emily Broad Leib, Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods, 61…
-
The Psychedelic Therapies Executive Order
November 19, 2026
I. Glenn Cohen, Holly Fernandez Lynch & Amy L. McGuire, The Psychedelic Therapies Executive Order, JAMA (2026).
-
Setting, context and the regulatory atmospheres of psychedelic medicine
November 19, 2026
Alex K. Gearin, I. Glenn Cohen & Albert Garcia-Romeu, Setting, context and the regulatory atmospheres of psychedelic medicine, 153 International Journal of Drug Policy (2026).
-
Medical Aid in Dying State Laws: A Thirty Year Evolution
November 19, 2026
Eli Y. Adashi & I. Glenn Cohen, Medical Aid in Dying State Laws: A Thirty Year Evolution, 38 The Journal of the American Board of…
-
The FDA’s Leucovorin Approval—A Departure From Evidentiary Standards
November 19, 2026
Daniel G. Aaron, Michael S. Sinha & I. Glenn Cohen, The FDA’s Leucovorin Approval—A Departure From Evidentiary Standards, JAMA (2025).
-
The Right to Contraception Act: A Present-Day Imperative
November 19, 2026
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The Right to Contraception Act: A Present-Day Imperative, 34 J. Women’s Health 164 (2025).
-
The US FDA’s New Rule for Regulating Laboratory-Developed Tests
November 19, 2026
Daniel G. Aaron, Eli Y. Adashi & I. Glenn Cohen, The US FDA’s New Rule for Regulating Laboratory-Developed Tests, 5 JAMA Health F. (2024).
-
Checks and Balances on FDA’s Authority
November 19, 2026
Holly Fernandez Lynch, Peter Lurie & I. Glenn Cohen, Checks and Balances on FDA’s Authority, JAMA (2024).
-
Food and Drug Omnibus Reform Act: A Critical Course Correction
November 19, 2026
Aditya Narayan, I. Glenn Cohen & Eli Y. Adashi, Food and Drug Omnibus Reform Act: A Critical Course Correction, 99 Mayo Clinic Proc. 869 (2024).
-
Paying for Over-the-Counter Contraception: The Opill Quandary
November 19, 2026
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, Paying for Over-the-Counter Contraception: The Opill Quandary, 3 Am. J. Med. 200 (2024).
-
The FDA Declares Levonorgestrel a Nonabortifacient—A 50-Year Saga Takes a Decisive Turn
November 19, 2026
Eli Y. Adashi, I. Glenn Cohen & Allen J. Wilcox, The FDA Declares Levonorgestrel a Nonabortifacient—A 50-Year Saga Takes a Decisive Turn, 8 JAMA Health…
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional, Am. J. Med.
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The Inflation Reduction Act: Recasting the Medicare Prescription Drug Plans, Am. J. Preventative Med. (2023).
-
Eli Y. Adashi & I. Glenn Cohen, The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials, 36 J. Am. Bd. Fam. Med.
-
Assessing—and Extending—California’s Insulin Manufacturing Initiative
November 19, 2026
Jacob S. Sherkow, Eli Y. Adashi & I. Glenn Cohen, Assessing—and Extending—California’s Insulin Manufacturing Initiative, JAMA (2023).
-
Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation
November 19, 2026
Patricia J. Zettler, Eli Y. Adashi & I. Glenn Cohen, Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation, 388 New…
-
The FDA Struggle to Withdraw Makena
November 19, 2026
Daniel G. Aaron, I. Glenn Cohen & Eli Y. Adashi, The FDA Struggle to Withdraw Makena, JAMA (2022).